greeksoup/ stock research
Stock research / United States / GEHC / Q1 FY2022

GE HealthCare Technologies (GEHC) Q1 FY2022 earnings: revenue $4.3 billion

GE HealthCare Technologies Inc. (GEHC) reported revenue of $4.3 billion for Q1 FY2022, the quarter ended 31 March 2022. Net income was $389 million, and diluted earnings per share $0.86. The figures are the company's own, from the 10-Q it filed with the SEC on 25 April 2023.

Revenue
$4.3 billion
Q1 FY2022Q1 FY2022
Operating margin
11.7%
Q1 FY2022Q1 FY2022
Net income
$389 million
Q1 FY2022Q1 FY2022
Diluted EPS
$0.86
Q1 FY2022Q1 FY2022

this quarterthe same quarter a year earlierHover a bar for its figure.

Income statement (profit and loss)

$ millionQ1 FY2022Quarter beforeA year earlierOn the quarterOn the yearLast 8 quarters
Revenue4,343n/an/a
Gross profit1,678n/an/a
Gross margin38.6%n/an/a
Research and development238n/an/a
Selling, general and administrative931n/an/a
Operating income509n/an/a
Operating margin11.7%n/an/a
Pre-tax income533n/an/a
Income tax131n/an/a
Effective tax rate24.6%n/an/a
Net income389n/an/a
Net margin9.0%n/an/a
Diluted EPS$0.86n/an/a
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionQ1 FY2022Quarter beforeA year earlierOn the quarterOn the yearLast 8 quarters
Operating cash flow468n/an/a
Capital expenditure100n/an/a
Free cash flow368n/an/a
Free cash flow margin8.5%n/an/a
Cash from investing-100n/an/a
Cash from financing-420n/an/a
Depreciation and amortisation159n/an/a
Share-based compensation19.0n/an/a
Dividends paid0.0n/an/a
Diluted shares, weighted454mn/an/a
Shares outstanding at period end455mn/an/a

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet

$ millionQ1 FY2022Quarter beforeA year earlierOn the quarterOn the yearLast 8 quarters
Shareholders' equity16,578n/an/a
Redeemable equity229n/an/a
Cash and equivalents506n/an/a

Questions

What was GE HealthCare Technologies' revenue in Q1 FY2022?

GE HealthCare Technologies (GEHC) reported revenue of $4.3 billion for Q1 FY2022, the quarter ended 31 March 2022.

How much did GE HealthCare Technologies earn in Q1 FY2022?

Net income for Q1 FY2022 was $389 million, and diluted earnings per share $0.86.

When did GE HealthCare Technologies report Q1 FY2022 results?

GE HealthCare Technologies filed its 10-Q for the quarter ended 31 March 2022 with the SEC on 25 April 2023.

Quarterly results, the last 19 quarters

Q1 FY2022Q2 FY2022Q3 FY2022Q4 FY2022 *Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026
Revenue4,3434,4844,5764,9384,7074,8174,8225,2064,6504,8394,8635,3204,7775,0075,1435,6985,1315,2955,513
Gross profit1,6781,7961,7731,9321,8911,9401,9352,1561,9022,0022,0262,2752,0121,9851,9902,2611,9772,1802,224
Gross margin39%40%39%39%40%40%40%41%41%41%42%43%42%40%39%40%39%41%40%
R&D238257260271270298322315324327316344344302292322345323320
SG&A9319089088841,0621,0729961,1521,0381,0671,0341,1301,0401,0291,0451,1111,1171,1181,100
Operating income509631605777559570617689540608676801629654653827515739805
Operating margin12%14%13%16%12%12%13%13%12%13%14%15%13%13%13%15%10%14%15%
Pre-tax income533639622718546570636609512578658833692613643820505693752
Tax rate25%24%21%21%30%24%39%32%24%25%26%12%15%18%28%27%19%17%17%
Net income389485487555372418375403374428470721564486446588389561615
Net margin9%11%11%11%8%9%8%8%8%9%10%14%12%10%9%10%8%11%11%
Diluted EPS$0.86$1.07$1.07$1.22$0.41$0.91$0.82$0.88$0.81$0.93$1.02$1.57$1.23$1.06$0.98$1.29$0.85$1.24$1.36
Operating cash flow468-19.0622n/a468-67.0650n/a419-119n/an/a25094.0593n/a290168907
Capital expenditure10059.074.077.014370.080.094.014564.090.010215286.0110134178100114
Free cash flow368-78.0548n/a325-137570n/a274-183n/an/a98.08.0483n/a11268.0793
Buybacksn/an/an/an/an/an/an/an/an/an/a0.0n/a0.01001000.01002000.0
Dividends paid0.00.00.0n/a0.014.014.013.014.014.013.014.016.016.016.016.016.016.016.0
Shares outstanding455m455m455mn/a455m455m455m455m456m457m457m457m458m457m456m456m455m452m452m
Filing10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-Q for the period ended 31 March 2022, filed 25 April 2023: the filing.